Relation between agendas of the research community and the research consumer
The LancetPublished 1 June 2000
Deborah Tallon, Jiri Chard, Paul Dieppe
Citations430
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
There is a mismatch between the amount of published work on different interventions, and the degree of interest of consumers, and it is suggested that broadening of the research agenda would be more in line with current treatment patterns and consumer views.
Abstract
There is a mismatch between the amount of published work on different interventions, and the degree of interest of consumers. We suggest that broadening of the research agenda would be more in line with current treatment patterns and consumer views. If this mismatch is not addressed, then evidence-based medicine will not be representative of consumer needs.
Keywords
Health ProfessionsPharmacology, Toxicology and Pharmaceutics
The Discovery of Grounded Theory
23,416 Citations2017Barney G. Glaser, Anselm L. Strauss
The LancetLanguage bias in randomised controlled trials published in English and German
1,026 Citations1997Matthias Egger, Tanja Zellweger-Zähner +4 more
English language bias may be introduced in reviews and meta-analyses if they include only trials reported in English if authors are more likely to report trials with statistically significant results in English than in German.
JAMAFactors Influencing Publication of Research Results
853 Citations1992Kay Dickersin
There was evidence of publication bias in that for both institutional review boards there was an association between results reported to be significant and publication and contrary to popular opinion, publication bias originates primarily with investigators, not journal editors.
New England Journal of MedicineThe Relation between Funding by the National Institutes of Health and the Burden of Disease
504 Citations1999Cary P. Gross, Gerard F. Anderson +1 more
A cross-sectional study comparing estimates of disease-specific funding in 1996 with data on six measures of the burden of disease found that the acquired immunodeficiency syndrome, breast cancer, diabetes mellitus, and dementia all received relatively generous funding, regardless of which measure was used as the basis for calculating support.
Archives of Internal MedicineA Study of Manufacturer-Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of Arthritis
277 Citations1994Paula A. Rochon
The manufacturer-associated NSAID is almost always reported as being equal or superior in efficacy and toxicity to the comparison drug, and claims of superiority, especially in regard to side effect profiles, are often not supported by trial data.
Archives of Internal MedicineA study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
275 Citations1994Paula A. Rochon
BMJWhat do I want from health research and researchers when I am a patient?
210 Citations1995Iain Chalmers
The impression is left that health researchers could serve the interests of the public more effectively in a variety of ways, and that they would be helped to do so by greater lay involvement in planning and promoting health research.
BMJDeprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health
207 Citations1996Jenny Eachus, Mark Williams +5 more
The heavy burden of disease in the most deprived groups, particularly among elderly people, warrants attention in planning of the health service and resource allocation.
JAMAFactors influencing publication of research results. Follow-up of applications submitted to two institutional review boards
194 Citations1992Kay Dickersin
Journal of the Royal College of Physicians of LondonWho Will Challenge Evidence-Based Medicine?
36 Citations1999Neville W. Goodman
Clinical RiskWho Will Challenge Evidence-Based Medicine?
17 Citations2000Neville W. Goodman
Evidence-based medicine, which lays special emphasis on the formal gathering and synthesis of research data by systematic review and meta-analysis, is intuitively attractive as a way of determining best treatments.